Search results for " market"
Article
Reconciling Sensor Communication Gaps
For Kelsey McNeel, market segment manager, process analytics at Hamilton (Reno, NV), the key issue for bioprocess monitoring and controls is reconciling information obtained at bench- or process-devel…
Article
Drug Quality Key to Innovation and Access
…n 2015, raising concerns about current incentives and regulatory processes for bringing new drugs to market. FDA has approved numerous breakthrough therapies for cancer and critical conditions based …
Article
The Tide Stays High
Equity markets’ appetite for public offerings from emerging bio/pharmaceutical companies had significantly diminished: valuations of emerging bio/pharma companies, as measured by the NASDAQ Biotechnol…
Article
Automating Processes in Upstream Processing
If the place of record for data no longer resides on a paper record, then the integrity of the data, how it is produced and stored in the PCS is a key component for the disposition of batches to the m…
Article
Modeling Bioreactor Performance
Most widely used are commercially available computational fluid dynamics (CFD) software packages, according to Christel Fenge, vice-president of product management and marketing for fermentation techn…
Article
Process Chromatography Selection for Downstream Processing Applications
…erra-Arteaga, PhD, purification team manager, MSAT at MilliporeSigma; and Peter Levison, PhD, senior marketing director of Downstream Processes at Pall Life Sciences discuss important considerations …
Article
A Second Modular Biopharma Facility Opens: KUBio in Hangzhou
To bring advanced biosimilar products to the Chinese market quickly, Pfizer’s Global Biotechnology Center will make use of Cytiva’s KUBio advanced modular manufacturing solution. KUBio modules …
Article
Downstream Processing Continues to Worry CMOs
Single-use devices to the rescue?
To get a better sense of how the biopharmaceutical manufacturing market is positioning itself to deal with these problems, respondents were asked to identify acti…
Poster
Unlocking the potential for efficiency in downstream bioprocesses
Additionally, flexibility needs to be increased and time to market reduced. Upstream processes are more efficient and product higher titers than before. With these improvements, new challenges arise. …
Article
Continuous Processing for the Production of Biopharmaceuticals
While there is a plethora of emerging continuous bioprocessing technologies available in the market, there are almost no concrete examples of successful implementation and integration of a fully conti…